CERO - CERO THERAPEUTICS HOLDINGS, INC.

QQQ $ 604.54 $ 0.00 (0 %)

DIA $ 463.95 $ 0.00 (0 %)

SPY $ 666.69 $ 0.00 (0 %)

TLT $ 90.92 $ 0.00 (0 %)

GLD $ 388.74 $ 0.00 (0 %)

Previous Close

$ 2.6

Open

$ 2.87

Bid

$ 2.68 x 151

Ask

$ 2.70 x 2

Day's Range

-- - --

52 Week Range

$ 2.58 - $ 895.40

Volume

436,823

Average Volume

Market Cap

759

Beta (5Y Monthly)

$ 0.01

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-22-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	04-15-2025	12-31-2024	10-K
4	11-19-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-17-2024	03-31-2024	10-Q
7	04-02-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-24-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-13-2022	03-31-2022	10-Q
15	03-24-2022	12-31-2021	10-K
16	11-19-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

D. Boral Capital Maintains Buy on CERo The...
10/13/2025 14:43:04

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

'CERo Therapeutics CEO: We're "open" to ta...
10/10/2025 18:12:38

https://www.axios.com/pro/biotech-deals/2025/10/10/cero-therapeutics-ceo-open-takeover-offers

Cero Therapeutics Has Received A Decision ...
09/26/2025 19:59:01

https://register.epo.org/application?number=EP22758100

D. Boral Capital Maintains Buy on CERo The...
09/23/2025 11:20:32

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Doses Third Patient In P...
09/22/2025 13:18:07

Third patient in the first cohort is now advancing through protocol-defined evaluations as Company anticipates additional resul...

top-3-health-care-stocks-youll-regret-missing-in-q3

Top 3 Health Care Stocks You'll Regret Mis...
09/09/2025 13:12:17

D. Boral Capital Maintains Buy on CERo The...
09/09/2025 12:41:27

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Secures U.S. And Japanes...
09/09/2025 12:18:26

Additional patent granted from the Japanese patent office now results in 20 granted patents and allowed applications covering t...

12 Health Care Stocks Moving In Monday's I...
09/08/2025 17:07:17

CERo Therapeutics Has Administered Second ...
09/08/2025 12:47:05

CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo" or the "Company") an innovative cellular immunotherapy ...

D. Boral Capital Maintains Buy on CERo The...
09/05/2025 18:11:40

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Receives FDA Fast Track ...
09/05/2025 12:11:03

12 Health Care Stocks Moving In Friday's P...
09/05/2025 12:07:53

why-docusign-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket

Why Docusign Shares Are Trading Higher By ...
09/05/2025 09:20:59

CERo Therapeutics Hldgs Q2 EPS $(61.71) Mi...
08/22/2025 21:20:00

CERo Therapeutics Hldgs (NASDAQ:CERO) reported quarterly losses of $(61.71) per share which missed the analyst consensus estima...

D. Boral Capital Maintains Buy on CERo The...
08/04/2025 11:37:13

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

CERo Therapeutics Doses Second Patient In ...
07/31/2025 12:11:19

Second patient in the first cohort is now advancing through protocol-defined evaluations as Company provides promising update o...

CERo Therapeutics To Offer Up To 12.5M Sha...
07/21/2025 20:43:18

-SEC Filing

D. Boral Capital Maintains Buy on CERo The...
06/24/2025 12:14:41

D. Boral Capital analyst Jason Kolbert maintains CERo Therapeutics Hldgs (NASDAQ:CERO) with a Buy and maintains $30 price ta...

12 Health Care Stocks Moving In Monday's A...
06/23/2025 21:06:48